Market Newsdesk

December 30, 2020 12:03 pm

Cboe IBHY Futures Set Single-Day Volume and Notional Value Records

IBHY futures traded a record high of nearly 4,500 contracts, with a notional value of approximately $650 million, on Monday, December 28

IBIG futures see second highest trading day of all-time this week

PR Newswire

CHICAGO, Dec. 30, 2020 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), a market operator and global trading solutions provider, today announced that trading in Cboe® iBoxx® iShares® $ High Yield Corporate Bond Index (Ticker: IBHY) futures set a new daily volume record on Monday, December 28, with a reported 4,451 contracts traded, representing more than $648 million in notional value. This new record surpasses the previous high of 3,891 contracts traded on October 28, 2020.

In addition, Cboe® iBoxx® iShares® $ Investment Grade Corporate Bond Index (Ticker: IBIG) futures reached their second highest daily volume of all-time on Monday, December 28 with a reported 610 contracts traded, representing more than $92 million in notional value. Both IBHY and IBIG futures are traded on Cboe Futures Exchange, LLC (CFE).

Designed to leverage the deep and liquid iShares® ETF ecosystem, IBHY and IBIG futures are based on indices designed to measure the performance of U.S. dollar-denominated high yield and investment grade corporate debt, and offer broad coverage for the liquid U.S. high yield and investment grade corporate bond universes.

Michael Mollet, Vice President, Head of Futures, said: “Since April of this year, we’ve seen steady growth in volume of both IBHY and IBIG futures as investors look to tailor their exposure to the nearly $9 trillion U.S. corporate bond market. We believe an exchange-traded, centrally cleared instrument brings tremendous utility to the space by providing market participants a transparent, standardized tool to help with efficient credit risk mitigation or to implement fixed income trading strategies.”

Cboe’s corporate bond index futures began trading in fall 2018. IBHY futures are cash-settled futures on IHS Markit’s iBoxx® iShares® $ High Yield Corporate Bond Index (IBXXIBHY Index) and IBIG futures are cash-settled futures on IHS Markit’s iBoxx® iShares® $ Investment Grade Corporate Bond Index (IBXXIBIG Index).

For additional information on CFE’s IBHY and IBIG futures, including contract specifications, product fact sheets and daily market statistics, visit: www.cboe.com/iboxx.

About Cboe Global Markets, Inc.

Cboe Global Markets (Cboe: CBOE) provides cutting-edge trading and investment solutions to market participants around the world. The company is committed to defining markets through product innovation, leading edge technology and seamless trading solutions.

The company offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S., Canadian and European equities, exchange-traded products (ETPs), global foreign exchange (FX) and volatility products based on the Cboe Volatility Index (VIX Index), recognized as the world’s premier gauge of U.S. equity market volatility.

Cboe’s subsidiaries include the largest options exchange and the third largest stock exchange operator in the U.S. In addition, the company operates one of the largest stock exchanges by value traded in Europe, and owns EuroCCP, a leading pan-European equities clearing house. Cboe also is a leading market globally for ETP listings and trading.

The company is headquartered in Chicago with a network of domestic and global offices across the Americas, Europe and Asia, including main hubs in New York, London, Kansas City and Amsterdam. For more information, visit www.cboe.com.

Media Contacts		Analyst Contact
Angela Tu	Tim Cave		Debbie Koopman
+1-646-856-8734	+44 (0) 7593-506-719		+1-312-786-7136
[email protected]	[email protected]		[email protected]

Cboe®, Cboe Global Markets®, Cboe Volatility Index®, CFE®, and VIX® are registered trademarks and Cboe Futures Exchange^SM is a service mark of Cboe Exchange, Inc. All other trademarks and service marks are the property of their respective owners.

Futures trading is not suitable for all investors and involves the risk of loss. That risk of loss can be substantial and can exceed the amount of money deposited for a futures position. You should, therefore, carefully consider whether futures trading is suitable for you in light of your circumstances and financial resources. You should put at risk only funds that you can afford to lose without affecting your lifestyle. For additional information regarding futures trading risks, see the Risk Disclosure Statement set forth in Appendix A to CFTC Regulation 1.55(c) and the Risk Disclosure Statement for Security Futures Contracts.

The iBoxx® iShares® $ High Yield Corporate Bond Index and the iBoxx® iShares® $ Investment Grade Corporate Bond Index (the “Indexes”) referenced herein are the property of Markit Indices Limited (“Index Sponsor”) and have been licensed for use in connection with Cboe® iBoxx® iShares® $ High Yield Corporate Bond Index Futures and Cboe® iBoxx® iShares® $ Investment Grade Corporate Bond Index Futures. Each party to a Cboe® iBoxx® iShares® $ High Yield Corporate Bond Index Futures or Cboe® iBoxx® iShares® $ Investment Grade Corporate Bond Index Futures transaction acknowledges and agrees that the transaction is not sponsored, endorsed or promoted by the Index Sponsor. The Index Sponsor makes no representation whatsoever, whether express or implied, and hereby expressly disclaims all warranties (including, without limitation, those of merchantability or fitness for a particular purpose or use), with respect to the Indexes or any data included therein or relating thereto, and in particular disclaims any warranty either as to the quality, accuracy and/or completeness of the Indexes or any data included therein, the results obtained from the use of the Indexes and/or the composition of the Indexes at any particular time on any particular date or otherwise and/or the creditworthiness of any entity, or the likelihood of the occurrence of a credit event or similar event (however defined) with respect to an obligation, in the Indexes at any particular time on any particular date or otherwise. The Index Sponsor shall not be liable (whether in negligence or otherwise) to the parties or any other person for any error in the Indexes, and the Index Sponsor is under no obligation to advise the parties or any person of any error therein.

The Index Sponsor makes no representation whatsoever, whether express or implied, as to the advisability of purchasing or selling Cboe® iBoxx® iShares® $ High Yield Corporate Bond Index Futures and Cboe® iBoxx® iShares® $ Investment Grade Corporate Bond Index Futures, the ability of the Indexes to track relevant markets’ performances, or otherwise relating to the Indexes or any transaction or product with respect thereto, or of assuming any risks in connection therewith. The Index Sponsor has no obligation to take the needs of any party into consideration in determining, composing or calculating the Indexes. No party purchasing or selling Cboe® iBoxx® iShares® $ High Yield Corporate Bond Index Futures or Cboe® iBoxx® iShares® $ Investment Grade Corporate Bond Index Futures, nor the Index Sponsor, shall have any liability to any party for any act or failure to act by the Index Sponsor in connection with the determination, adjustment, calculation or maintenance of the Indexes. iBoxx® is a service mark of IHS Markit Limited.

The iBoxx® iShares® $ High Yield Corporate Bond Index and the iBoxx® iShares® $ Investment Grade Corporate Bond Index (the “Indexes”) and futures contracts on the Indexes (“Contracts”) are not sponsored by, or sold by BlackRock, Inc. or any of its affiliates (collectively, ” BlackRock”). BlackRock makes no representation or warranty, express or implied to any person regarding the advisability of investing in securities, generally, or in the Contracts in particular. Nor does BlackRock make any representation or warranty as to the ability of the Index to track the performance of the fixed income securities market, generally, or the performance of HYG, LQD or any subset of fixed income securities.

BlackRock has not calculated, composed or determined the constituents or weightings of the fixed income securities that comprise the Indexes (“Underlying Data”). BlackRock is not responsible for and has not participated in the determination of the prices and amounts of the Contracts, or the timing of the issuance or sale of such Contracts or in the determination or calculation of the equation by which the Contracts are to be converted into cash (if applicable). BlackRock has no obligation or liability in connection with the administration or trading of the Contracts. BlackRock does not guarantee the accuracy or the completeness of the Underlying Data and any data included therein and BlackRock shall have no liability for any errors, omissions or interruptions related thereto.

BlackRock makes no warranty, express or implied, as to results to be obtained by Markit or its affiliates, the parties to the Contracts or any other person with respect to the use of the Underlying Data or any data included therein. BlackRock makes no express or implied warranties and expressly disclaims all warranties of merchantability or fitness for a particular purpose or use with respect to the Underlying Data or any data included therein. Without limiting any of the foregoing, in no event shall BlackRock have any liability for any special, punitive, direct, indirect or consequential damages (including lost profits) resulting from the use of the Underlying Data or any data included therein, even if notified of the possibility of such damages.

iShares® is a registered trademark of BlackRock Fund Advisors and its affiliates.

View original content to download multimedia:http://www.prnewswire.com/news-releases/cboe-ibhy-futures-set-single-day-volume-and-notional-value-records-301199408.html

SOURCE Cboe Global Markets, Inc.

December 30, 2020 12:03 pm

Ynvisible Welcomes Seda Evis to Advisory Board and to Close Private Placement

Ynvisible Welcomes Seda Evis to Advisory Board and to Close Private Placement

VANCOUVER, British Columbia–(BUSINESS WIRE)–Ynvisible Interactive Inc. (the “Company” or “Ynvisible”) (TSX-V: YNV, FSE: 1XNA, OTCQB: YNVYF) is excited to strengthen its Advisory Board with the addition of Seda Evis, a business, user-centered design and finance leader. By uniting business expertise, research talent, and financial resources, Ynvisible aims to build innovative solutions and technology standards that provide an easy visual interface for the Internet of Things (IoT). Seda Evis is joining the Ynvisible Advisory Board as Ramin Heydarpour has joined the Ynvisible Board of Directors as of December 2020.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201230005293/en/

Seda Evis is joining the Ynvisible Advisory Board (Photo: Business Wire)

INDUSTRY LEADERS

Ynvisible has infused the Advisory Board with leaders in private and academic sectors, specializing in Supply Chain Management, Packaging, Consumer Insights, Engineering, Business, and Finance.

Seda Evis joins Mitchell Huang, Adam Laubach, Dr. Rudi Leuschner, Sal Pellingra, and Tiffany Vasilchik, Dr. Michael Okoroafor, Dr. Harlan Byker, and Dr. Harri Kopola.

These inspiring professionals work collaboratively with like-minded experts and organizations to cultivate deeper relationships between industry, government, and financial partners. Ultimately, this infusion of new perspectives will transform the entire Ynvisible value chain.

Michael Robinson, COO of Ynvisible, says, “Ynvisible’s ability to return shareholder and customer value hinges on our Customer Experience (CX) and our capacity to rapidly and iteratively build, measure and learn around our products and services. A robust CX practice has been shown to deliver double- and triple-digit ROI. Seda Evis brings a wealth of customer-centered insight that I’m very excited to integrate to support our continued growth in 2021 and beyond.”

Seda Evis is an award-winning business leader, combining strategy with design process and user-centered insights leading to growth. She designs new products, services, businesses that spark change for Fortune 500 companies such as Amazon, Nike, Toyota, Philips, GE, Herman Miller, with persistence to see it through from vision to build. Seda is a Designer-in-Residence at the University of California San Diego’s DesignLab, led by Don Norman. She’s also an incoming board member at Design Forward Alliance, a non-profit that promotes human-centered design as a tool to help advance San Diego as a premier city for business, education, and enjoyment.

She holds an Urban Design and Planning degree from Middle East Technical University in Ankara, Turkey, with a minor in Architectural Conservation and a Masters in Business Administration from the University of San Diego.

PRIVATE PLACEMENT

Ynvisible announces that it will be closing, subject to acceptance by the TSX Venture Exchange, a non-brokered private placement of 12,857,142 Units of the Company (the “Units”) at $0.35 per Unit to raise gross proceeds of $4,500,000 (the “Offering”), whereby each Unit shall consist of one common share in the capital of the Company (“Share”) and one-third (1/3) of one Share purchase warrant (“Warrant”). Each whole Warrant, subject to an acceleration provision, will be exercisable into an additional Share at an exercise price of $0.50 for a period of 18 months from the date of issuance.

Jani-Mikael Kuusisto, Chief Executive Officer of Ynvisible, stated, “We are very pleased with the interest in our financing and to see several institutional investors investing into Ynvisible. This private placement, pending closing, combined with the recent exercises of warrants, is set to strengthen our cash position by more than $5 million. This significantly increases our runway and allows our team to further accelerate our business with more resources for customer delivery and customer service, plus an increased focus on building and monetizing our products business.”

In connection with the Offering, applicable finders’ fees to eligible finders will comprise (i) cash commissions in an aggregate amount of $68,628, and (ii) an aggregate of 452,280 finders’ units. The finders’ units will bear the same terms and conditions of the Units, consisting of one Share and one-third (1/3) of one Warrant, exercisable into an additional Share at an exercise price of $0.50 for a period of 18 months from the date of issuance.

All securities issued pursuant to the Offering shall be subject to a statutory four-month hold period from the date of closing in accordance with applicable Canadian securities laws. The Offering’s net proceeds will be used for general working capital, productization, marketing, and increasing production capacity.

EXERCISING OF WARRANTS

At the commencement of Ynvisible’s FY2020 Q3, the Company had 8,978,478 Warrants issued and outstanding, whereby each Warrant was exercisable into a Share at an exercise price of $0.60. These Warrants were issued pursuant to private placement financings that closed in January and June 2019. A total of 1,027,505 of these Warrants have recently been exercised generating proceeds of $616,503.

ABOUT YNVISIBLE INTERACTIVE INC.

Ynvisible aims to be a leading company in the emerging printed and flexible electronics sector. Given the cost and power-consumption advantages over conventional electronics, printed electronics are a key enabler of mass adoption of the Internet of Things (“IoT”) and smart objects. Ynvisible has the experience, know-how and intellectual property in electrochromic materials, inks, and systems. Ynvisible’s interactive printed graphics solutions solve the need for ultra-low power, mass deployable, & easy-to-use electronic displays and indicators for everyday smart objects, IoT devices, and ambient intelligence (intelligent surfaces). Ynvisible offers a mix of services, materials and technology to brand owners developing smart objects and IoT products. Additional information on Ynvisible is available at www.ynvisible.com

ON BEHALF OF THE BOARD OF DIRECTORS

“Jani-Mikael Kuusisto,” CEO, Ynvisible Interactive Inc.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking statements. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. All statements, other than statements of historical fact, that address activities, events or developments the Company believes, expects or anticipates will or may occur in the future, including, without limitation, statements about the Company’s forecast of sales, cost of sales, operating expenses and income from other sources; the Company’s business strategy, plans and outlooks; the future financial or operating performance of the Company; and future marketing and operating plans are forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company. Factors that could cause actual results or events to differ materially from current expectations include, among other things: the impact of COVID-19; risks and uncertainties related to additional costs being subsequently identified and the allocation of costs between reporting periods; and the possibility that the actual financial results will not be consistent with the Company’s expectations. Actual results may differ materially from those currently anticipated in such statements. Readers are encouraged to refer to the Company’s public disclosure documents for a more detailed discussion of factors that may impact expected future results. The Company undertakes no obligation to publicly update or revise any forward-looking statements, unless required pursuant to applicable laws.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201230005293/en/

“Jani-Mikael Kuusisto,” CEO, Ynvisible Interactive Inc.

Investor Relations

+1 778-683-4324

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Technology Networks Hardware

MEDIA:

Photo

Seda Evis is joining the Ynvisible Advisory Board (Photo: Business Wire)

December 30, 2020 12:03 pm

Société Générale SA shareholding notification

30 December 2020 18:00 CET

ArcelorMittal (‘the Company’) announces that Société Générale SA has notified it of an increase in actual and potential shareholding (voting rights) in ArcelorMittal from 4.3% to 5.2%, based on a form submitted on 30 December 2020. The underlying transaction took place on 24 December 2020. The notification is available in the Luxembourg Stock Exchange’s electronic database OAM on www.bourse.lu and on http://corporate.arcelormittal.com under ‘Investors – Corporate Governance – Shareholding structure’.

This notification was published in reference to the Luxembourg law and the Grand Ducal regulation of 11 January 2008, on transparency requirements for issuers of securities (‘Transparency Law’) in view of a shareholding notification going above the 5% voting rights threshold.

ENDS

About ArcelorMittal

ArcelorMittal is the world’s leading steel and mining company, with a presence in 60 countries and primary steelmaking facilities in 18 countries. In 2019, ArcelorMittal had revenues of U.S.$70.6 billion and crude steel production of 89.8 million metric tonnes, while iron ore production reached 57.1 million metric tonnes.

Our goal is to help build a better world with smarter steels. Steels made using innovative processes which use less energy, emit significantly less carbon and reduce costs. Steels that are cleaner, stronger and reusable. Steels for electric vehicles and renewable energy infrastructure that will support societies as they transform through this century. With steel at our core, our inventive people and an entrepreneurial culture at heart, we will support the world in making that change. This is what we believe it takes to be the steel company of the future.

ArcelorMittal is listed on the stock exchanges of New York (MT), Amsterdam (MT), Paris (MT), Luxembourg (MT) and on the Spanish stock exchanges of Barcelona, Bilbao, Madrid and Valencia (MTS).

For more information about ArcelorMittal please visit:

http://corporate.arcelormittal.com/


Contact information ArcelorMittal Investor Relations

Europe	+44 20 7543 1156
Americas	+1 312 899 3985
Retail	+44 20 7543 1156
SRI	+44 207543 1156
Bonds/Credit	+33 171 921 026


Contact information ArcelorMittal Corporate Communications
E-mail:	[email protected]
Phone:	+442076297988


ArcelorMittal Corporate Communications

Paul Weigh	+44 20 3214 2419

December 30, 2020 11:58 am

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – PNM, TNAV, SNSS, ZAGG, ELY

PR Newswire

NEW YORK, Dec. 30, 2020 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

PNM Resources, Inc. (NYSE: PNM)

concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Avangrid, Inc. for $50.30 in cash per share. If you are a PNM shareholder, click here to learn more about your rights and options.

Telenav, Inc. (NASDAQ: TNAV)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to V99, Inc., a corporation led by HP Jin, Co-Founder, President, and Chief Executive Officer of Telenav, for $4.80 per share. If you are a Telenav shareholder, click here to learn more about your rights and options.

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)

concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Viracta Therapeutics, Inc. Sunesis stockholders are expected to own approximately 14% of the combined company on a fully diluted basis. If you are a Sunesis shareholder, click here to learn more about your rights and options.

ZAGG Inc (NASDAQ: ZAGG)

concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a buyer group led by Evercel, Inc. Under the terms of the merger, ZAGG shareholders will receive $4.20 per share in cash, and an additional contingent amount of up to $0.25 per share to be paid if ZAGG’s Paycheck Protection Program Loan is forgiven and any audit related thereto is satisfactorily completed. If you are a ZAGG shareholder, click here to learn more about your rights and options.

Callaway Golf Company (NYSE: ELY)

concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Topgolf Entertainment Group. Under the terms of the merger agreement, Callaway will issue approximately 90 million shares of common stock to Topgolf shareholders. If you are a Callaway shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llp-investigates-the-following-mergers–pnm-tnav-snss-zagg-ely-301199360.html

SOURCE Halper Sadeh LLP

December 30, 2020 11:54 am

InvestorBrandNetwork Concludes Coverage and 6th Year of Sponsorship of LD Micro Main Event

LOS ANGELES, Dec. 30, 2020 (GLOBE NEWSWIRE) — (via InvestorWire) — InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, has completed its coverage of the LD Micro Main Event, one of the largest and most influential independent conferences in the small-cap space. A six-year sponsor of LD Micro, IBN participated in this year’s Main Event to engage with executives from hundreds of public companies that presented at the conference. IBN also provided widespread exposure through published corporate overviews that were syndicated to 5,000 downstream partners and delivered social media coverage for participating companies.

IBN has 15+ years of experience helping client partners and events improve and magnify communications within the investment community. With a growing platform of 50+ investor-oriented brands, IBN has amassed a collective audience that includes millions of social media followers. IBN is the most disruptive provider in the corporate communications industry and the only firm to offer a truly comprehensive communications solution to reach new audiences on an ongoing basis.

IBN has written and published 50,000+ articles and press releases while representing more than 500 public and private companies. Powered by a sophisticated support team and significant investments in syndication technology, IBN delivers a unique corporate communications solution that more companies are recognizing as the most effective way to communicate their messaging.

For more information, please visit: http://www.InvestorBrandNetwork.com or call (310) 402-2681 to set up a Live Demonstration via IBN Studios

About InvestorBrandNetwork

The InvestorBrandNetwork (“IBN”) consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.

For more information on IBN, visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

December 30, 2020 11:48 am

The Community Financial Corporation Announces Quarterly Cash Dividend

WALDORF, Md., Dec. 30, 2020 (GLOBE NEWSWIRE) — The Community Financial Corporation (NASDAQ: TCFC) (the “Company”) announced today that its Board of Directors has declared a quarterly cash dividend of $0.125 per share of common stock. The dividend will be paid on or about January 25, 2021 to stockholders of record as of the close of business on January 11, 2021.

The Community Financial Corporation is the bank holding company for Community Bank of the Chesapeake, which conducts business through its main office in Waldorf, Maryland, and branch offices in Bryans Road, California, Charlotte Hall, Dunkirk, La Plata, Leonardtown, Lusby, Prince Frederick and Waldorf, Maryland and Fredericksburg, Virginia.

Forward-looking Statements – This news release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements can generally be identified by the fact that they do not relate strictly to historical or current facts. They often include words like “believe,” “expect,” “anticipate,” “estimate” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could” or “may.” Statements in this release that are not strictly historical are forward-looking and are based upon current expectations that may differ materially from actual results. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. These risks and uncertainties involve general economic trends, changes in earnings, changes in interest rates, loss of deposits and loan demand to other financial institutions, substantial changes in financial markets, changes in real estate value and the real estate market, regulatory changes, possibility of unforeseen events affecting the industry generally, the uncertainties associated with newly developed or acquired operations, the outcome of pending litigation, and market disruptions and other effects of terrorist activities. The Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unforeseen events, except as required under the rules and regulations of the Securities and Exchange Commission.

CONTACT:
William Pasenelli
President and Chief Executive Officer
240-427-1033

December 30, 2020 11:38 am

TAB Bank Provides $4 Million Senior Credit Facility to The Good Bean

OGDEN, Utah, Dec. 30, 2020 (GLOBE NEWSWIRE) — TAB Bank is pleased to announce it has entered into a multi-year agreement with The Good Bean to provide a $4 million revolving credit facility. The facility was used to provide for the company’s ongoing working capital needs as it continues grow and expand the reach of its portfolio of healthy plant-based snacks, confections, and other innovations.

Founded by in 2010, The Good Bean is a Berkeley, CA based manufacturer and wholesaler of plant-based foods centered on the notion that “Beans Are Better”.

The Good Bean snacks are all-natural, vegan, and NON-GMO verified. The company takes great pride in sourcing the most delicious, minimally processed ingredients available with a commitment to regenerative agriculture in the US and promoting justice, equality, and diversity in the food industry.

The company’s products can be found in stores across the US and Canada, including Walmart, HEB, Safeway, Kroger, Publix, Loblaws, CVS, Rite Aid, 7-11. Costco, and on Amazon.com.

“For a growing company, working with a trusted source of working capital is a necessity, but partnering with my colleagues at TAB reaches beyond a banking relationship into a sustained partnership that is supportive and aligned in a way that is rare, in my experience. I look forward to us growing together in the years to come.” said Sarah Wallace, Co-Founder and CEO of The Good Bean.

”TAB is excited to partner with The Good Bean to support their mission to bring healthy and nutritious bean and plant-based snack products to the masses. TAB was able to understand the dynamic working capital requirements of this business and deliver the right solution; we are excited to be the company’s financial partner and look forward to building a long and successful working relationship” stated Brett Horwitz, TAB’s Managing Director and Head of Originations in the Western Region.

TAB Bank provides custom working capital solutions to commercial businesses across a wide range of industries. These solutions can be customized to meet the needs of companies in all stages of the business life cycle and during any economic conditions. TAB Bank does this through a variety of asset-based structures including Asset-Based Revolving Loans, Accounts Receivable Financing, Lines of Credit, and Equipment Finance. TAB’s lending options can also be combined with a full suite of business banking solutions and Treasury Management Services.

Brett Horwitz
is TAB Bank’s Managing Director & Head of Originations for the Western Region based in Los Angeles. Brett has years of experience developing client relationships and structuring credit facilities in the asset-based lending arena. Brett can be reached at 949.466.5255 or at [email protected].

Contact Information:

Trevor Morris
Director of Marketing
801-624-5172
[email protected]
Twitter – @TABBank
Facebook – facebook.com/TABbank

December 30, 2020 11:31 am

Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S.

Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S.

CAMBRIDGE, Mass. & STOCKHOLM–(BUSINESS WIRE)–
Moderna, Inc. (NASDAQ:MRNA), biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Recipharm (STO: RECI-B), a leading contract development and manufacturing organization (CDMO), today announced that they have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 Vaccine supply outside of the U.S. The activity will be performed in Recipharm’s drug product manufacturing facility located in France.

Subject to regulatory approval of the vaccine in relevant countries outside of the U.S., it is anticipated that supply will commence in early 2021.

“We are making important progress in the development of the Moderna COVID-19 Vaccine and we are pleased to be entering into this collaboration with Recipharm,” said Nicolas Chornet, Senior Vice President, International Manufacturing of Moderna. “We look forward to their support in the delivery of our vaccine to market.”

“This is a material and strategically important agreement for us, and we are delighted to be working with Moderna on such a vital project to support the long-term fight against COVID-19,” said Thomas Eldered, CEO of Recipharm. “Our preparations are already well underway with the hiring of new staff and investment in the facility to enable us to meet the challenging timelines.”

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. The company’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense, and Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.

About Recipharm

Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s annual turnover is approximately SEK 11 billion. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.

For more information on Recipharm and our services, please visit www.recipharm.com.

Special Note Regarding Forward-looking Statements

This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the terms of the collaboration between Recipharm and Moderna for the formulation, filling and finishing of pharmaceutical products, including the Moderna COVID-19 Vaccine, and the timing for commencement of supply of the vaccine. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could”, “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others: the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response technology in use by Moderna is still being developed and implemented; the safety, tolerability and efficacy profile of the Moderna COVID-19 Vaccine observed to date may change adversely in ongoing analyses of trial data or subsequent to commercialization; despite having ongoing interactions with the FDA or other regulatory agencies, the FDA or such other regulatory agencies may not agree with Moderna’s regulatory approval strategies, components of the company’s filings, such as clinical trial designs, conduct and methodologies, or the sufficiency of data submitted; Moderna may encounter delays in meeting manufacturing or supply timelines or disruptions in its distribution plans for the Moderna COVID-19 Vaccine; whether and when any biologics license applications and/or emergency use authorization applications may be filed and ultimately approved by regulatory authorities; potential adverse impacts due to the global COVID-19 pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions, adverse effects on healthcare systems and disruption of the global economy; and those other risks and uncertainties listed under the heading “Risk Factors” in Moderna’s most recent quarterly report on Form 10-Q filed with the SEC and in subsequent filings made by Moderna with the SEC, which are available on Moderna’s website at www.modernatx.com and on the SEC’s website at www.sec.gov. Except as required by law, Moderna and Recipharm each disclaim any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise.

Recipharm Statement

This information is information that Recipharm AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above on 29 December 2020 at 17:20 CET.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201230005278/en/

Moderna Contacts

Media:

Colleen Hussey

Director, Corporate Communications

617-335-1374

[email protected]

Investors:

Lavina Talukdar

Senior Vice President & Head of Investor Relations

617-209-5834

[email protected]

Recipharm Contacts

Thomas Eldered, CEO, telephone: +46 8 602 52 10

Jean-François Hilaire, Executive Vice President, telephone: +33 695 447 507

Tobias Hägglöv, CFO, [email protected], telephone: +46 8 602 52 00 

KEYWORDS: Massachusetts Europe Sweden United States North America

INDUSTRY KEYWORDS: Research Infectious Diseases Clinical Trials Cardiology Other Health Biotechnology General Health Pharmaceutical Health Science

MEDIA:

Logo

December 30, 2020 11:30 am

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – RP, RNET, HMSY, MDCA, QEP

PR Newswire

NEW YORK, Dec. 30, 2020 /PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RealPage, Inc. (NASDAQ: RP)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $88.75 in cash per share. If you are a RealPage shareholder, click here to learn more about your rights and options.

RigNet, Inc. (NASDAQ: RNET)

concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Viasat, Inc. for 0.1845 Viasat common shares for each RigNet common share. If you are a RigNet shareholder, click here to learn more about your rights and options.

HMS Holdings Corp. (NASDAQ: HMSY)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Gainwell Technologies for $37.00 in cash per share. If you are an HMS shareholder, click here to learn more about your rights and options.

MDC Partners Inc. (NASDAQ: MDCA)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stagwell Media LP. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. If you are an MDC shareholder, click here to learn more about your rights and options.

QEP Resources, Inc. (NYSE: QEP)
concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Diamondback Energy, Inc. for 0.05 shares of Diamondback common stock for each share of QEP common stock. If you are a QEP shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

December 30, 2020 11:26 am

PUCA Pure & Care High Quality And Affordable Hyaluronic Acid Hydration Serum Perfect to Moisturize Dry Skin During Winter

Danish Beauty Products Now Available in the U.S.

PALM BEACH, FL, Dec. 30, 2020 (GLOBE NEWSWIRE) — Winter is no friend to your skin, which is why a moisturizer is your “best friend forever” when the chill begins.

The wintry wind and indoor heat can cause your skin to dry, flake, and even crack.

To keep your skin glowing and radiant, skincare experts suggest you upgrade your moisturizer and use it often during winter.

“The winter is harsh on your skin,” said Vivian Dynesen, founder and CEO of the Danish beauty company, PUCA Pure and Care. “To prevent dry, flaky skin, moisturizing is a must.”

PUCA Pure and Care’s most popular skincare products are now available in America, including Hyaluronic Acid Hydration Serum, a luxury moisturizer.

The benefits of Hyaluronic Acid are well known.

“Our serum with Hyaluronic Acid adds moisture to dry, tired, and dull skin,” Ms. Dynesen said. “It helps balance the skin’s moisture level and decreases the appearance of fine lines and wrinkles.”

PUCA Pure and Care’s Hyaluronic Acid Hydration Serum is cruelty-free, silicone-free, and alcohol-free with a natural scent.

Ms. Dynesen said PUCA Pure and Care skincare products combine nature and science to develop luxury wellness and skincare products that consumers desire at an affordable price.

“PUCA Pure and Care’s concept is care and moisture for your skin,” Ms. Dynesen added. “Our products contain natural oils, plant extracts, and use the latest scientific research to develop our skincare brand.”

PUCA Pure & Care products now available on VitaBeauti.com include:

Collagen Serum, which stimulates the skin’s collagen, promotes skin elasticity, decreases the appearance of fine lines and wrinkles, and promotes balanced moisture levels in the skin.
Hyaluronic Acid Hydration Serum, which adds moisture to dry, tired and dull skin. The serum promotes balanced moisture levels of the skin, decreases the appearance of fine lines and wrinkles, and stimulates the skin’s collagen. This serum nourishes the skin with unique moisturizing plant extracts and nutrients.
Vitamin C Serum, which reduces the appearance of dark spots on the skin. The filling effect brightens the appearance of the color and texture of the skin, reduces the appearance of wrinkles and fine lines, and stimulates the skin’s collagen.
Pure Gold Serum, which contains 24K gold, helps stimulates the skin’s natural collagen to keep the skin looking plump and firm. The serum maintains the skin’s youthful appearance.
Retinol Day Cream, which is an anti-aging day cream, delivers extra moisture and care. Retinol cream is based on a high content of the two highly active substances, Proline and Adenosine, which help reduce the signs of premature aging, help protect against further age spots, and help reduce the appearance of redness in the skin, and help stimulate and renew the skin.
Retinol Vitamin A Night Cream, which is a potent anti-aging cream. The cream, which contains Retinol, promotes the production of collagen and elastin.

“PUCA Pure and Care stands for luxury wellness and care products at affordable prices,” Ms. Dynesen said.

For more information, visit VitaBeauti.com.

Attachments

Robert Grant
PUCA PURE & CARE
561-421-3045
[email protected]